Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma

J. Chlumsky (Prague, Czech Republic)

Source: Annual Congress 2001 - Assessment and monitoring of inflammation in COPD and asthma
Session: Assessment and monitoring of inflammation in COPD and asthma
Session type: Poster Discussion
Number: 2222
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Chlumsky (Prague, Czech Republic). Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma. Eur Respir J 2001; 16: Suppl. 31, 2222

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers of airways inflammation in patients with severe asthma in a real clinical practice
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019


Markers of severity and inflammatory profile during exacerbations of severe asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017

Follow-up of patients with severe asthma by noninvasive parameters of airway inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 52s
Year: 2001

Clinical characteristics of asthma patients with small airway dysfunction
Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases
Year: 2020

Cinical assessment of asthma severity partially corresponds to eosinophilic airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 508s
Year: 2002

Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice
Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019
Year: 2020



Smoking and airway inflammation in asymptomatic subjects and in patients with chronic airway disease
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002

Clinical parameters predict the risk of acute exacerbation of COPD better than bronchial obstruction degree
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001

The relationship between persistent systemic inflammation and symptoms of depression among patients with COPD in the ECLIPSE cohort
Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation
Year: 2013

The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011


Current control, airway inflammation, and subsequent exacerbation in patients with asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Clinical relevance of airway remodelling in airway diseases
Source: Eur Respir J 2007; 30: 134-155
Year: 2007



Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008

The relationship between bronchial inflammation and markers of disease progression in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 179s
Year: 2003

On relationship between local and systemic chronic inflammation and between level of hypoxia and bronchial obstruction in COPD pts
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Phenotypic markers of asthma and COPD at the tissue level
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005

Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006

Small airways disease evaluation in patients with mild/moderate asthma and correlation with bronchial hyperresponsiveness and disease control
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018

The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020